Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
4.0
Merck & Co., Inc. is a U.S.-based pharmaceutical company operating in the Healthcare sector, with a strong focus on innovative medicines, vaccines, and biotechnology. Headquartered in the United States, the company serves global markets through research, manufacturing, and commercial operations across multiple regions.
Merck maintains a diversified portfolio across key therapeutic areas:
-
Oncology: Including immunotherapy treatments for various cancers.
-
Vaccines: Preventive solutions for infectious diseases.
-
Immunology and Infectious Diseases: Therapies targeting complex immune-related conditions.
-
Cardiometabolic and Other Specialty Areas: Treatments for chronic diseases.
-
Animal Health: Veterinary pharmaceuticals and vaccines.
The company operates in more than 100 countries, serving hospitals, governments, pharmacies, and healthcare systems. Its business model combines innovative drug development, global distribution, and long-term research investment.
Merck employs tens of thousands of people worldwide and supports its pipeline through research centers, manufacturing facilities, and strategic partnerships. Its shares trade on the New York Stock Exchange (NYSE) under the ticker MRK.
History and Development
Merck & Co., Inc. was established in the late 19th century as the U.S. subsidiary of the German pharmaceutical company Merck KGaA.
During World War I, the U.S. government separated the American operations from the German parent company, transforming Merck into an independent U.S.-based corporation.
In the decades that followed, the company expanded its pharmaceutical research capabilities and became a key supplier of medicines and vaccines in the U.S. market.
From the mid-20th century onward, Merck significantly increased its investment in scientific research, contributing to advancements in vaccines, cardiovascular treatments, and other therapeutic innovations.
In recent years, the company has strengthened its oncology and biotechnology portfolio while investing in research technologies and global collaborations to support long-term pipeline development.
Today, Merck & Co., Inc. positions itself as a research-driven pharmaceutical company with global scale, diversified therapeutic exposure, and a strong focus on innovation in complex disease treatment.
Additional Information
Merck & Co. Inc. (United States) is listed on the NYSE and has a market capitalization of $305.21 Billions, with shareholders equity totaling $-.
The company employs approximately 74.000 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Merck & Co. Inc. reported $65.01 Billions in revenue, generating net income of $18.25 Billions.
Key financial metrics include a P/E ratio of 16.72, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 2.70%.
The company trades under the ticker MRK.
